Position in BCAB
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,586
-$4,337 QoQ
Shares Held
1,108
-98.0% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 21 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 11%
Shared 0%
None 89%
Common Shares in BCAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,716,934,888 across 523 Biotechnology names. BCAB ranks #438 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in BCAB
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,586 | 1,108 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $8,923 | 55,426 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $24,793 | 43,653 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $10,612 | 15,426 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $124,965 | 315,571 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $206,668 | 595,587 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $652,715 | 1,104,428 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $3,270,389 | 1,858,176 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $2,541,029 | 1,854,768 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $6,570,894 | 1,910,144 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $4,706,260 | 1,913,115 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $2,721,337 | 1,600,788 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $5,075,667 | 1,691,889 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $5,034,434 | 1,878,521 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $15,026,249 | 1,821,364 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $12,687,779 | 1,647,764 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,074,512 | 1,078,778 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $7,969,955 | 1,593,991 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $12,960,488 | 660,239 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $6,882,627 | 233,785 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $591,369 | 13,954 | Shares | Defined | 2021-08-23 | |
| 2020-12-31 | $6,802 | 200 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||